Delivery Order SPE2DB24D2013-SPE2DB25FCKDF
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- AmerisourceBergen Drug Corp was awarded a delivery order for Copaxone 40 mg/ml syringes valued at $1,041.36 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. This competitive, firm fixed-price contract has an ultimate completion date of August 20, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $4,368 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $10,510.43 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/ml syringes. The contract, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, carries firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a $3,943.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a direct procurement of pharmaceutical supplies to support federal medical needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the federal government, with particular emphasis on...
- The Defense Logistics Agency has awarded a firm fixed price delivery order contract worth $1,069.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of COPAXONE 40 MG/ML syringes. The contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,583.28 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is to supply COPAXONE 40 MG/ML syringes, a specialty pharmaceutical product, with a period of performance through July 29, 2024. This order is placed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999, to provide a wide range of medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,583.28 firm fixed price delivery order contract (SPE2DX15D2109|SPE2DX24F0L9D) by the Defense Logistics Agency (DLA) Troop Support Medical to provide Copaxone 40 mg/ml syringes. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COPAXONE 40 MG/ML SYRINGE medication. The $6,333.12 contract has a completion date of January 31, 2024 and does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is a prime contractor that supplies pharmaceuticals, medical...